Innovative ETFs ChannelConsider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021By Max ChenDecember 31, 2020
Disruptive Technology ChannelBad Ideas: The Industries on Innovation’s Chopping BlockBy Max ChenNovember 17, 2020
Innovative ETFs Channel5 Reasons Why Investors Should Consider a Healthcare ETFBy Max ChenNovember 3, 2020
Equity ETF ChannelETF Strategies to Tap into Medical Breakthroughs, Healthcare InnovationsBy Max ChenOctober 30, 2020
Innovative ETFs ChannelAn Outperforming ETF for a Post-Coronavirus Pandemic WorldBy Max ChenAugust 27, 2020
Multi-Factor ChannelHow to Gain Exposure to the Next Generation of HealthcareBy Max ChenAugust 26, 2020
Innovative ETFs ChannelBiotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 ResearchBy Max ChenJuly 7, 2020
Innovative ETFs ChannelBiotech ETFs Rally After Inovio Locks in DOD Coronavirus DealBy Max ChenJune 23, 2020
Disruptive Technology ChannelWhy ETF Investors Should Consider Allocating to InnovationBy Max ChenMay 14, 2020
Disruptive Technology ChannelMaking the Case for Innovation: Rethinking Traditional Asset AllocationBy Max ChenMay 13, 2020
Equity ETF ChannelHealth Care Sector ETFs May Not Be so Defensive This Time AroundBy Max ChenMay 1, 2020
